Korea Investment Partners

Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YG Entertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.

Yer-hyun Baek

CEO and President

Yer Hyun Baek

President

Hak Sung Chang

MD

Steve Hong

Manager

Man-soon Hwang

Senior MD and Venture Director

Sang Hyuk Jang

Associate

Hyeong-sun Jeon

Principal

Stephanie Seung-Hi Kang

Director

Jae Hong Kim

Head of PE Group, Director

Min-kyu Kim

Director

Kun-ho Kim

Principal

Dong-yeob Kim

Executive Director

Chang-ho Kim

Executive Director and Venture Partner

Hwang Kim

Executive Director

Yong-Jae Kim

Head of Management Support, MD

Won-Bae Lee

Executive Director

Ke Liu

Principal

Jin-han Park

Senior Principal

Young-ho Park

Senior Principal

Hyeong-jun Park

Principal

Minsik Park

Director

Ji Woong Park

Executive Director

Deok Joon Shin

Director

Deok-joon Shin

Director

Ping Wang

Associate Partner

Jerry Hai Xu

Principal and Director

Sung-wook Yoo

Principal

362 past transactions

D'CENT

Seed Round in 2018
D'CENT provides cryptocurrency hardware wallet for keeping crypto assets secure.

Frequency Therapeutics

Series A in 2017
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

Cocoonbeat

Private Equity Round in 2015
Cocoonbeat

Crossbar

Series C in 2014
Crossbar Inc. develops and licenses resistive RAM technology for storing data on a single chip. Its products are used in consumer electronics, mobile phones, tablet computers, and cars to stores personal entertainment, data, photos, and information; enterprise storage, solid-state drives, and cloud computing; and connected thermostats, smart meters, and industrial sensors. Crossbar Inc. was founded in 2008 and is based in Santa Clara, California.

Crowdworks

Series B in 2019
CrowdWorks, Inc. develops online crowd sourcing platform for artificial intelligent (AI) which engages in collecting, strengthening, and structuring leaning data for machine learning. The company offers its services for analysis and classifying of image works, text works, voice works, and survey works. The company is based in Seoul, South Korea.

TEMCO Labs

Seed Round in 2018
TEMCO is a Blockchain-based supply and e-commerce open market platform. They aim to revolutionize supply chain management through innovative technology using Blockchain and smart contracts. TEMCO project will provide greater transparency and reliability across the supply chain process to deliver trustworthy information that empowers businesses and consumers.

Systran

Private Placement in 2020
Since its foundation in 1968, SYSTRAN has been pioneering machine translation technology. The company leads the industry with a number of breakthrough innovations and solutions now commonly used by companies and consumers. With a strong focus on research and development, SYSTRAN is 50 years later, more innovative than ever. Now introducing its Neural Machine Translation enterprise solution, SYSTRAN is bringing the capabilities of Neural translation to corporate users.

Haoxinqing

Series A in 2020
Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic disease management.

Limbix

Series A in 2021
Virtual is a developer of prescription digital therapeutics platform intended to help mental health treatment. The company's tool adheres to strict compliance with FDA quality management standards and also is put through rigorous research trials and in certain cases is paired with existing pharmacological treatments, as well as uses virtual reality to administer VR exposure therapy, assign CBT assessments or exercises and track patient progress, enabling patients to overcome anxiety, phobia and obsessive-compulsive disorder easily.

Doosan Mobility Innovation

Venture Round in 2022
Doosan Mobility Innovation focuses on the mobile applications of fuel cell technology.

Reach Robotics

Series A in 2017
Reach Robotics is creating the next gaming platform by combining Robotics, Gaming and AR. This means video game characters in real life that appear to be alive and can engage in various game modes, unlocking lots of potentials. The robots they make are more than connected toys, they are consistently evolving entertainment platforms. Their flagship product, MekaMon, has propelled us to the forefront of consumer robotics and they continue to evolve to ensure the future is always within reach.

eBrace

Series B in 2020
Guangzhou eBrace Biotechnology Co., Ltd. engages in the research, development, production, and sale of orthodontic biological materials. It offers 3D custom printing orthodontic teeth products. The company was founded in 2010 and is based in Guangzhou, China.

Swiggy

Series I in 2020
Swiggy provides a complete food ordering and delivery solution from the best neighborhood restaurants to the urban foodie. Swiggy aims to stand out by offering a more curated list of restaurants and services, not to mention its own in-house delivery fleet that pick up orders from restaurants and deliver it to the customers. It charges between 15-40 percent in commission to restaurants and for smaller orders, customers pay an additional delivery charge between 20 and 50 rupees depending on their city. Currently, Swiggy is in eight cities where it has more than 9,000 restaurants on its platform.

Zoyi

Series B in 2017
Zoyi Corporation develops customer analytic tools for retailers. The company offers Walk Insights, an offline retail analytics solution, that detects wireless signals from mobile devices to collect and store visitor data in real time. It also analyzes data from outside traffic, store visits, dwell time, and returning visitors. The company is based in Seoul, South Korea.

Tiki

Private Placement in 2018
Tiki Corporation retails books, electronics, home appliances, gifts, fashion, beauty, and health products. The company also offers phone, digital equipment and accessories, electrical appliances, life house products, beauty and health products, stationery, vehicles, toys and souvenirs, mother and baby sports products, air ticket booking, and international goods. It sells its products through online store. The company was founded in 2010 and is based in Ho Chi Minh City, Vietnam.

Newlinks Technology

Series D in 2020
Newlinks Technology is a car refueling service provider, mainly providing one-button cardless refueling service. The application recommends a gas station for the user and offers membership subscription, discounts, and more. In addition, it also provides car maintenance, 4S services, tire services, auto insurance, car care, and other services. Newlinks Technology was founded on 2016.

Uberple

Series B in 2018
Uberple, Inc. owns and operates an online real-time statistical computing engine for financial research. Uberple, Inc. was founded in 2013 and is based in Seoul, South Korea.

Mockang Mock Co., Ltd.

Private Placement in 2020
Mockang Mock Co., Ltd. develops a platform where users upload and watch makeup videos. The company is based in Seoul, South Korea.

PILAB

Seed Round in 2019
PILAB is a research-focused blockchain company that develops multipurpose software that enables communication and management of data across different platforms. PILAB is backed by South Korean venture capital firm Korea Investment Partners.

Actym Therapeutics, Inc.

Private Placement in 2020
Actym is a biotechnology company that focuses on developing an immuno-oncology platform. It specializes in the fields of medical device, manufacturing, and distribution. It focuses on a novel tumor-targeting, systemically-delivered STING pathway agonist that demonstrates robust anti-tumor. It was founded in 2017 and headquartered in San Francisco, California.

StyleShare

Series C in 2018
StyleShare is a realtime mobile and online platform that allows users to share and receive updates on fashion and beauty. With millions of users from 120 different countries, StyleShare is the top mobile platform for those interested in everyday fashion and beauty. Based in Seoul, South Korea, StyleShare has garnered the attention of VOGUE, Instyle, and Elle Japan as the No. 1 mobile fashion application.

Social Network

Venture Round in 2015
Social Network, a specialist platform servicing Korean trends.

JOYCITY Corporation (KOSDAQ:A067000)

Private Placement in 2020
JOYCITY Corporation operates as a gaming company worldwide. It designs, develops, and services games for multiple platforms, including PC online, mobile, VR, and console. The company was formerly known as JC Entertainment Corp and changed its name to JOYCITY Corporation in June 2013. JOYCITY Corporation was founded in 1994 and is based in Seongnam-si, South Korea.

Innogen Pharmaceutical

Venture Round in 2021
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Rabbit Care

Series B in 2020
Rabbit Care is your first choice for insurance and banking advise. We provide great customer experience through our digital platform and customer care center.

Friendsgames Co., Ltd.

Private Placement in 2018
Friendsgames Co., Ltd., a mobile game company, develops social network games, hard-core role-playing games, and social casino games. It also publishes games on various platforms, such as Apple iOS, Google Android, and Facebook. Friendsgames Co., Ltd. was formerly known as Supernova11 Co., Ltd. and changed its name to Friendsgames Co., Ltd. The company was founded in 2015 and is based in Seoul, South Korea.

Riiid

Series B in 2018
Established in 2014, Riiid is a global leading AI Tutor solution provider delivering creative disruption to the education market through its cutting-edge AI technology. Having launched Santa TOEIC in 2017, the firm’s first commercialized AI Tutor solution based on deep learning algorithm which has garnered 1 million users solely in Korea market with proven efficacy, Riiid leads the era of AI-based education in true sense. Leveraging the firm’s highly scalable and proven AI solution, Riiid is aggressively expanding its business to new test areas as well as into new geographical markets. It currently operates Santa TOEIC in Japan and has launched Santa SAT in Vietnam. Riiid aims at replacing hard copy textbooks and traditional lectures with AI Tutor. Through the firm's technology, any individual student gains access to a personalized AI tutor that far outpaces human tutors in terms of learning efficacy at a fraction of the cost. Driving the democratization and equalization of educational opportunities, Riiid is transforming learning and the industry landscape in remarkable and rapid fashion.

Prokarium

Series B in 2020
Prokarium is a developer of microbial genetics product designed for targeted vaccines and cancer immunotherapies. The company's product generates broad immune responses including mucosal, systemic and cellular immunity for the treatment of solid tumours as well as other oral vaccines, enabling doctors to evaluate the safety and immunogenicity of the bivalent vaccine.

Swit

Private Placement in 2018
Swit Technologies, Inc. develops an application software that provides team collaboration services. The company was founded in 2017 and is based in San Francisco, California.

Matchmade

Series A in 2018
The time for performance-driven influencer marketing is here. Matchmade is an easy-to-use platform that brings advertisers and influencers together for targeted and measured campaigns.

Ujipin

Series B in 2015
Ujipin is a web-based platform that focuses on lifestyle brands. It was launched in 2011. Ujipin is operated from Beijing, China.

Twiggle

Series B in 2017
Twiggle Ltd. develops a search technology that allows a search engine mimic a salesperson. It offers a natural language analyzer that uses natural language processing to extract linguistic intent from customer queries and a universal product ontology for product search. The company provides Twiggle's Semantic API, a plug-and-play semantic search application programming interface (API) that integrates into existing search engines and provides a natural language layer that allows search engineers and data scientists to enhance search logic and present results to shoppers. Twiggle Ltd. was founded in 2013 and is headquartered in Tel Aviv, Israel with an additional office in New York, New York.

Enlivex Therapeutics

Series B in 2017
Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells. Enlivex is developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach to inducing immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.

Bioinfra Life Science

Private Placement in 2019
BIOINFRA Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea. Its portfolio includes cancer screening test technology, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment. The company was founded in 2001 and is based in Seoul, South Korea.

Innogen Pharmaceutical

Venture Round in 2022
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

G2GBIO

Series A in 2018
G2GBIO operates to supply good medicines to patients all over the world and practice.

Laundrygo

Series B in 2020
Laundrygo is a on-demand laundry service.

eToro (Europe) Ltd.

Private Placement in 2018
eToro Europe Ltd. offers online security brokerage services and trades currencies, commodities, indices, and CFD stocks online. Its platform allows users to trade financial instruments. The company’s platform also supplies various financial analysis tools. eToro Europe Ltd. was formerly known as RetailFX Limited. The company was founded in 2006 and is based in Limassol, Cyprus. eToro Europe Ltd. operates as a subsidiary of eToro Group Limited

IGAWorks

Series D in 2019
IGAWorks is an full stack ad-tech company founded on 2006, and we are a group of industry-leading global services for the smart success of digital marketing and mobile businesses. We provide full-stack of ad-tech services which follows: ‘Tradingworks’, agency trade desk offering media, audience, performance as total advertisement service; ‘adbrix’, an all-in-one data platform which leads the growth of mobile businesses with data based on the ad performance and user data; ‘adPOPcorn’, the biggest ad network in Korea; ‘Mobile Index‘, mobile app market analytics platform; ‘Campaign Intelligence’, reporting tool which dramatically lessens marketer’s reporting workload. Today, more than 30,000 mobile apps are utilizing the solutions of IGAWorks for their growth of businesses.

PAEAN Biotechnology Inc.

Private Placement in 2019
PAEAN Biotechnology Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of mitochondria-based pharmaceuticals to treat incurable diseases. It develops anti-inflammatory and anti-cancer biopharmaceuticals based on mitochondria isolated from human stem cells or platelet. Its pipelines include Mitochondrial Therapeutics for the treatment of inflammatory diseases related to mitochondria and mitochondrial dysfunction; Mitochondrial Cell Therapeutics; and precision medicines. The company was incorporated in 2013 and is based in Daejeon, South Korea with research and development centers in Seoul, Korea.

Frequency Therapeutics

Private Placement in 2019
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

Happyeasygo

Series B in 2019
HappyEasyGo is an India based local Online Travel Company. We are providing best air tickets and hotels with the lowest Price. Now you can book various airline tickets such as IndiGo, Jet airways, Go air, Spice Jet, air Asia, Vistara and Air India. We also provide you updated and verified Happy Easy Go instant discount hotels and special offers on flight tickets.

Newlinks Technology

Series C in 2019
Newlinks Technology is a car refueling service provider, mainly providing one-button cardless refueling service. The application recommends a gas station for the user and offers membership subscription, discounts, and more. In addition, it also provides car maintenance, 4S services, tire services, auto insurance, car care, and other services. Newlinks Technology was founded on 2016.

Vaccitech

Private Placement in 2018
Vaccitech Limited researches and develops T cell immunotherapeutic products and vaccines. The company offers hepatitis B virus (HBV) and human papillomavirus (HPV) therapeutic products and therapeutic vaccines for prostate cancer. The company was incorporated in 2016 and is based in Oxford, United Kingdom.

S-Alpha Therapeutics

Series A in 2021
S-Alpha Therapeutics Inc., a digital therapeutics company, researches and develops health applications and platform technologies that enable digital devices to treat different diseases. Its products include SAT-001, an ophthalmology related application for eye disease treatment; SAT-002, neurology application for treatment of nervous system disease; SAT-003, oncology application for recovery and treatment of cancer patients; and SAT-008, a public crisis application for overcoming social problems. Additionally, it also develops therapeutic devices. The company was founded in 2019 and is based in Seoul, South Korea.

Prokarium

Series A in 2018
Prokarium is a developer of microbial genetics product designed for targeted vaccines and cancer immunotherapies. The company's product generates broad immune responses including mucosal, systemic and cellular immunity for the treatment of solid tumours as well as other oral vaccines, enabling doctors to evaluate the safety and immunogenicity of the bivalent vaccine.

Halodoc

Private Placement in 2019
PT HaloDoc provides a communication platform that connects patients with doctors. It offers HaloDoc that enables users to connect with doctors through video calls, voice calls, and chat; order laboratory tests; and find the closest hospitals, clinics, and doctors. It also offers its service through its Website. PT HaloDoc was founded in 2016 and is based in Jakarta, Indonesia.

Popdog

Private Placement in 2018
Popdog, Inc. provides e-sports and game-focused online streaming services to players, teams, streamers, tournaments, publishers, agencies, and advertisers. It develops products designed to optimize e-sports and gaming live streaming. The company was incorporated in 2016 and is based in Santa Monica, California.

Viron Inc.

Series B in 2021
OncoMyx Therapeutics develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. The company's MYXV platform, is poised to be a best-in-class OV approach. The company assembled the top OV team around MYXV to advance a pipeline of oncology therapeutics for the benefit of cancer patients.

MEDIHERE

Private Placement in 2020
MEDIHERE Inc. provides online healthcare consultation services. It offers a subscription based service that provides patients with doctor's appointments and prescriptions with board-certified physicians who speak Korean and English. The company’s services are used by patients with chronic diseases and patients who find it hard to explain their symptoms due to language barrier. The company also provides B2B Program for enterprises that provides virtual primary care via chat/video call for employers. The company was incorporated in 2018 and is based in Seoul, South Korea.

eBrace

Private Placement in 2020
Guangzhou eBrace Biotechnology Co., Ltd. engages in the research, development, production, and sale of orthodontic biological materials. It offers 3D custom printing orthodontic teeth products. The company was founded in 2010 and is based in Guangzhou, China.

Nature republic

Private Equity Round in 2015
Argan Oil provides Supleness and Nutrition to damaged hair.

Enlivex Therapeutics

Private Placement in 2019
Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells. Enlivex is developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach to inducing immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.

KMW

Private Placement in 2018
Kmw Inc. develops and produces equipment, and parts and components for mobile communication base stations. Its products include filters, such as macro filters, black hole filters, micro bellows filters, and other products; site solutions that include multi-port antennas, omnidirectional antennas, and combiners, as well as other solutions, such as fixed clamps, adjustable clamps, 3 sector clamps, enhanced portable AISG controllers, and remote control tilting and steering products; and RRH, MMR, and RRA systems. It serves customers in Korea, the United States, Europe, and Asia. Kmw Inc. was founded in 1991 and is headquartered in Hwaseong, South Korea.

Riiid! Inc.

Private Placement in 2018
Riiid! Inc. develops a learning application platform based on artificial intelligence. The company was founded in 2014 and is based in Seoul, South Korea.

Shawya

Series A in 2019
Shawya is a skin care brand operator, which has a variety of product lines such as skin care, beauty, maternal and child, to meet the needs of users.

Crowdworks

Series B in 2019
CrowdWorks, Inc. develops online crowd sourcing platform for artificial intelligent (AI) which engages in collecting, strengthening, and structuring leaning data for machine learning. The company offers its services for analysis and classifying of image works, text works, voice works, and survey works. The company is based in Seoul, South Korea.

wadiz

Venture Round in 2017
Wadiz Corp. operates a crowdfunding platform for start ups. The company was incorporated in 2012 and is based in Seongnam, South Korea.

NRISE

Seed Round in 2020
NRISE is develops MOCI and WIPPY services. NRISE research and develops social media services to bring people the joy of communication.

Actym Therapeutics, Inc.

Series A in 2020
Actym is a biotechnology company that focuses on developing an immuno-oncology platform. It specializes in the fields of medical device, manufacturing, and distribution. It focuses on a novel tumor-targeting, systemically-delivered STING pathway agonist that demonstrates robust anti-tumor. It was founded in 2017 and headquartered in San Francisco, California.

Gaeasoft

Private Placement in 2020
Gaeasoft engages in the development, operation, maintenance, and marketing of wired and wireless systems. It operates through the following business divisions: Information Technology (IT) Service, advertising, and distribution and electronic commerce. The IT Service business division provides software development and maintenance. The advertising business division provides online marketing and advertising. The e-commerce business division engages in sale of organic food products and online business.

Bluesignum

Seed Round in 2023
We are developing a digital mental health guide that combines cognitive behavioral therapy techniques and Artificial Intelligence to help people self-manage their mental health. BlueSignum aims to go beyond the habit app space and build out its more complex services, establishing itself in the global healthcare app market. The AI Listener service BlueSignum is currently building will allow users to have a conversation with an AI speaker.

ABL Bio

Series B in 2017
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.

Meixin Global

Series A in 2017
Founded in 2015, Meixin provides a number of global wealth management products such as fixed income investments, real estate private equity fund, private equity investments and overseas hedge funds to Chinese high-net-worth individual clients. It also has a business-to-business platform providing global asset analysis and trading services for financial institutions such as asset management companies.

Prokarium

Private Placement in 2018
Prokarium is a developer of microbial genetics product designed for targeted vaccines and cancer immunotherapies. The company's product generates broad immune responses including mucosal, systemic and cellular immunity for the treatment of solid tumours as well as other oral vaccines, enabling doctors to evaluate the safety and immunogenicity of the bivalent vaccine.

Royalcrow Co., Ltd.

Private Placement in 2019
Royalcrow Co., Ltd. develops and distributes online games. The company was incorporated in 2018 and is based in Seongnam- Si, South Korea.

Apposter

Series B in 2022
Apposter is a Korean-based interactive solutions company engaged in providing UI development, app development, and mobile business consultancy solutions to its customers. Apposter has released many mobile apps and solutions to the enterprise market including, Fotofly, Life Valley, and Tok Song.

MCube

Series C in 2014
mCube, Inc. develops MEMS motion sensors and software solutions. It offers sensor components, sensor modules, and wearable sensor systems. The company’s products are used to measure, monitor, and analyze motion and context in space and generating massive amounts of data/insight. It offers products to customers online and through sales offices and distributors in the United States and internationally. Its products are used in Internet of Moving Things, wearable, hearable, medical, smartphone and tablets, 3d character animation, and human motion measurement. The company was founded in 2009 and is based in San Jose, California. It has locations in Hsinchu and Taipei, Taiwan; and Shenzhen and Shanghai, China.

Zhenge Biotech

Series A in 2020
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

LinearHub (Roundee.io)

Series A in 2017
We help users focus on the meeting and eliminate the time lost in post meeting follow up's. Roundee.io is a smart video meeting service with hassle free recording and rich post recording. Meeting information is not lost anymore. Roundee.io is integrated with commercial collaboration tools like Slack and Microsoft Teams(not launched yet), bringing all the meeting information in one place.

Traplight Oy

Venture Round in 2017
Traplight Oy develops mobile game communities where players can create and share their own games with their friends. Traplight Oy was incorporated in 2010 and is based in Tampere, Finland.

Fast Forward

Series A in 2022
Fast Forward is an app development company that operates DOMINO, an investment management app.

Kakao

Post in 2011
Kakao Pay is the financial technology division of Kakao. It allows over-counter payments, peer-to-peer transactions, bill payment, web banking and more, and it will move to offer financial services such as loans and financing. Kakao Pay is a platform that aims for a new financial effortless that is completely different from the existing and difficult and cumbersome finance beyond just cashless and wallet less life without cash or wallet.

Action Square

Series A in 2013
Action Square CO., LTD. develops mobile games in South Korea. It offers various games, such as blade, Three Kingdoms Blade, Blade 2, and Gigantic X. The company was founded in 2012 and is based in Seongnam, South Korea.

Infit & Company Inc.

Series A in 2018
Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

Enlivex Therapeutics

Venture Round in 2018
Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells. Enlivex is developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach to inducing immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.

RFHIC

Private Placement in 2020
RFHIC Corporation designs, manufactures, and sells RF and microwave components for the broadcasting, telecommunication, and defense markets in South Korea and internationally. The company offers MMICs that are designed as drive amplifiers; active dividers; gallium nitride (GaN) power transistors; connectorized power, pallet, wideband, cable TV hybrid, and low noise amplifiers; GaN transmit and receive, and SMD modules; variable attenuators; GaN MMICs; and microwave generator. The company offers its products for various applications, such as base stations, small cell, point-to-point, Wi-Fi, cable and broadband, radar, communication, ISM, and SATCOM applications. RFHIC Corporation was founded in 1999 and is headquartered in Anyang, South Korea.